Hormonal consequences of epilepsy and its treatment in men

Kartik Sivaraaman1, Scott Mintzer

  • 1Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Abstract

Insights

Epilepsy and its medications can disrupt male hormone balance and sexual function. Newer anticonvulsants may not impact testosterone levels or sexual health, unlike older drugs.

Area of Science:

  • Endocrinology
  • Neurology
  • Reproductive Medicine

Background:

  • Epilepsy and anticonvulsant drugs can disrupt endocrine function.
  • The male reproductive hormonal system is particularly susceptible to these disruptions.

Purpose of the Study:

  • To review the impact of epilepsy and its treatments on male reproductive hormones.
  • To understand the relationship between seizures, medications, and male sexual health.

Main Methods:

  • Review of existing literature on epilepsy, anticonvulsants, and male hormonal/sexual function.
  • Analysis of how seizures affect hypothalamic-pituitary-gonadal axis.
  • Evaluation of the role of cytochrome P450 induction by older anticonvulsants.

Main Results:

  • Seizures alter gonadotropin secretion; older anticonvulsants increase sex hormone-binding globulin, lowering bioactive testosterone.
  • Sexual dysfunction and infertility are common in men with epilepsy, though direct hormonal links are unclear.
  • Newer, non-P450 inducing anticonvulsants do not appear to affect testosterone or sexual function.

Conclusions:

  • Epilepsy and its treatments significantly alter male hormonal and sexual function.
  • Further research is needed to clarify mechanisms, as data can conflict.
  • Addressing psychiatric comorbidities and considering anticonvulsant therapy changes may benefit male patients.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...